Abstract
Deep learning can be used effectively to predict participants’ age from brain magnetic resonance imaging (MRI) data, and a growing body of evidence suggests that the difference between predicted and chronological age—referred to as brain-predicted age difference (brain-PAD)—is related to various neurological and neuropsychiatric disease states. A crucial aspect of the applicability of brain-PAD as a biomarker of individual brain health is whether and how brain-predicted age is affected by MR image artifacts commonly encountered in clinical settings. To investigate this issue, we trained and validated two different 3D convolutional neural network architectures (CNNs) from scratch and tested the models on a separate dataset consisting of motion-free and motion-corrupted T1-weighted MRI scans from the same participants, the quality of which were rated by neuroradiologists from a clinical diagnostic point of view. Our results revealed a systematic increase in brain-PAD with worsening image quality for both models. This effect was also observed for images that were deemed usable from a clinical perspective, with brains appearing older in medium than in good quality images. These findings were also supported by significant associations found between the brain-PAD and standard image quality metrics indicating larger brain-PAD for lower-quality images. Our results demonstrate a spurious effect of advanced brain aging as a result of head motion and underline the importance of controlling for image quality when using brain-predicted age based on structural neuroimaging data as a proxy measure for brain health.
Highlights
Two 3D CNNs trained from scratch and validated to predict age from T1-w brain MRI
Testing on motion-free and motion-corrupted scans from the same participants
Image quality assessed by neuroradiologists and using standard image quality metrics
Systematic increase in brain-predicted age difference with worsening image quality
Spurious advanced brain aging effect in scans deemed usable for clinical diagnostics
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by Project no. RRF-2.3.1-21-2022-00009 and RRF-2.3.1-21-2022-00011, which have been implemented with the support provided by the European Union, and by a grant from the Hungarian National Research, Development and Innovation Office (2019-2.1.7-ERA-NET-2020-00008) to Z.V.. Author B.W. was supported by the Consolidator Researcher program of the Óbuda University.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The research protocol used for collecting the data was designed and conducted in accordance with the Hungarian regulations and laws, and was approved by the National Institute of Pharmacy and Nutrition (file number: OGYÉI/70184/2017).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The MR-ART dataset is publicly available, the UK Biobank dataset is available by application, and the transfer learning dataset is available upon reasonable request to the authors.
